FOLH1 and posterior cortical atrophy: With its high sensitivity and specificity in PCa lesion detection [14, 15], positron emission tomography (PET) targeting prostate specific membrane antigen (PSMA) has gained an important role in PCa staging and treatment planning [16–19] and has shown large potential for non-invasive characterization of PCa [11, 20].